Journal of Medical Ethics 33 (9):538-540 (2007)

In this paper, the ethical and legal issues raised by the deactivation of implantable cardioverter-defibrillators in patients with terminal cancer is considered. It is argued that the ICD cannot be well described either as a treatment or as a non-treatment option, and thus raises complex questions regarding how rules governing deactivation should be framed. A new category called “integral devices” is proposed. Integral devices require their own special rules, reflecting their position as a “halfway house” between a form of treatment and a part of the body. The practical problems faced by doctors working in palliative medicine with regard to the deactivation of ICDs are also considered
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1136/jme.2006.017657
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 58,437
Through your library

References found in this work BETA

Killing and Letting Die.Helga Kuhse & Peter Singer - 2001 - In John Harris (ed.), Bioethics. Oxford University Press.

Add more references

Citations of this work BETA

Prolegomena to Any Future Mereology of the Body.Edward Fried - 2013 - Theoretical Medicine and Bioethics 34 (5):359-384.

Add more citations

Similar books and articles

Patient Complains of …: How Medicalization Mediates Power and Justice.Alison Reiheld - 2010 - International Journal of Feminist Approaches to Bioethics 3 (1):72-98.
Personalized Cancer Care in an Age of Anxiety.Susan Gilbert - 2010 - Hastings Center Report 40 (5):18-21.


Added to PP index

Total views
9 ( #898,820 of 2,420,968 )

Recent downloads (6 months)
4 ( #192,292 of 2,420,968 )

How can I increase my downloads?


My notes